ESR1 and breast cancer: A previous study analyzed chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) data for TFs, including FOXA1 and ESR1, in breast cancer cell lines to investigate the enrichment of TF-DNA bindings of genome-wide association studies (GWAS)-identified single nucleotide polymorphisms (SNPs)8.